The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
The anaplastic lymphoma kinase in the pathogenesis of cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S.-I., Watanabe, H., Kurashina, K., Hatanaka, H., et al. (2007) · Nature · doi:10.1038/nature05945 · Cited by 5,439
Hossfeld, D. K. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf146 · Cited by 4,625
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., & Look, A. T. (1994) · Science · doi:10.1126/science.8122112 · Cited by 2,409
Stein, H., Mason, D., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., et al. (1985) · Blood · doi:10.1182/blood.v66.4.848.848 · Cited by 1,846
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X.-M., Polakiewicz, R. D., & Comb, M. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1046 · Cited by 1,124
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Coffin, C. M., Hornick, J. L., & Fletcher, C. D. M. (2007) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213393.57322.c7 · Cited by 1,006
Stein, H., Foss, H., Dürkop, H., Marafioti, T., Delsol, G., Pulford, K. A. F., Pileri, S. A., & Falini, B. (2000) · Blood · doi:10.1182/blood.v96.12.3681 · Cited by 949
Grisendi, S., Mecucci, C., Falini, B., & Pandolfi, P. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1885 · Cited by 850
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 736
Iwahara, T., Fujimoto, J., Wen, D., Cupples, R., Bucay, N., Arakawa, T., Mori, S., Ratzkin, B., & Yamamoto, T. (1997) · Oncogene · doi:10.1038/sj.onc.1200849 · Cited by 726
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
Lawrence, B., Perez-Atayde, A., Hibbard, M. K., Rubin, B. P., Dal Cin, P., Pinkus, J. L., Pinkus, G. S., Xiao, S., Yi, E. S., Fletcher, C. D. M., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64550-6 · Cited by 714
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
Griffin, C. A., Hawkins, A. L., Dvorak, C. C., Henkle, C., Ellingham, T. J., & Perlman, E. J. (1999) · PubMed · Cited by 571
Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X., & Witte, D. P. (1997) · Oncogene · doi:10.1038/sj.onc.1201062 · Cited by 524
Bose, S., Deininger, M., Gora-Tybor, J., Goldman, J. M., & Melo, J. V. (1998) · Blood · doi:10.1182/blood.v92.9.3362 · Cited by 463
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E., & Inghirami, G. (2005) · Nature Medicine · doi:10.1038/nm1249 · Cited by 442
Self-citationTran, H., Brunet, A., Griffith, E. C., & Greenberg, M. E. (2003) · Science's STKE · doi:10.1126/stke.2003.172.re5 · Cited by 434
Hideshima, T., Catley, L., Yasui, H., Ishitsuka, K., Raje, N., Mitsiades, C., Podar, K., Munshi, N. C., Chauhan, D., Richardson, P. G., et al. (2006) · Blood · doi:10.1182/blood-2005-08-3434 · Cited by 422
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
Zamo, A., Chiarle, R., Piva, R., Howes, J., Fan, Y., Chilosi, M., Levy, D. E., & Inghirami, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205152 · Cited by 399
Self-citationIdentification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin
Stoica, G. E., Kuo, A., Aigner, A., Sunitha, I., Souttou, B., Malerczyk, C., Caughey, D. J., Wen, D., Karavanov, A., Riegel, A. T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010660200 · Cited by 382
Shiota, M., Nakamura, S., Ichinohasama, R., Abe, M., Akagi, T., Takeshita, M., Mori, N., Fujimoto, J., Miyauchi, J., & Mikata, A. (1995) · Blood · doi:10.1182/blood.v86.5.1954.bloodjournal8651954 · Cited by 380
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK
Galkin, A. V., Melnick, J. S., Kim, S., Hood, T. L., Li, N., Li, L., Xia, G., Steensma, R., Chopiuk, G., Jiang, J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609412103 · Cited by 379
Critical role for Gab2 in transformation by BCR/ABL
Sattler, M., Mohi, M. G., Pride, Y. B., Quinnan, L. R., Malouf, N. A., Podar, K., Gesbert, F., Iwasaki, H., Li, S., Van Etten, R. A., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00074-0 · Cited by 364
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal
Dijkers, P. F., Birkenkamp, K. U., Lam, E. W.-F., Thomas, N. S. B., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108084 · Cited by 363
Bischof, D., Pulford, K., Mason, D. Y., & Morris, S. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2312 · Cited by 363
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., Lui, M. Y., Colleoni, G. W. B., Antonescu, C. R., Ladanyi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61711-7 · Cited by 359
Stoica, G. E., Kuo, A., Powers, C., Bowden, E. T., Sale, E. B., Riegel, A. T., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205749200 · Cited by 357
Vaccines for tumour prevention
Lollini, P.-L., Cavallo, F., Nanni, P., & Forni, G. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1815 · Cited by 340
Bai, R.-Y., Ouyang, T., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2000) · Blood · doi:10.1182/blood.v96.13.4319 · Cited by 319
Piccaluga, P. P., Agostinelli, C., Califano, A., Rossi, M., Basso, K., Zupo, S., Went, P., Klein, U., Zinzani, P. L., Baccarani, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26833 · Cited by 303
Cools, J., Włodarska, I., Somers, R., et al. (2002) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10033 · Cited by 292
Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S., & Yamamoto, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4181 · Cited by 289
Hernández, L., Pinyol, M., Hernández, S., Beà, S., Pulford, K., Rosenwald, A., Lamant, L., Falini, B., Ott, G., Mason, D. Y., et al. (1999) · Blood · doi:10.1182/blood.v94.9.3265 · Cited by 287
Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells.
Graninger, W. B., Seto, M., Boutain, B., Goldman, P., & Korsmeyer, S. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113235 · Cited by 281
Bai, R.-Y., Dieter, P., Peschel, C., Morris, S. W., & Duyster, J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.6951 · Cited by 281
Fusion of ALK to the Ran‐binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor
Ma, Z., Hill, D. A., Collins, M. H., Morris, S. W., Sumegi, J., Zhou, M., Zuppan, C., & Bridge, J. A. (2003) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10177 · Cited by 280
Sebti, S. M., & Hamilton, A. D. (2000) · Oncogene · doi:10.1038/sj.onc.1204146 · Cited by 279
Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T., & Wasik, M. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.1.466 · Cited by 262
Słupianek, A., Nieborowska-Skorska, M., Hoser, G., Morrione, A., Majewski, M., Xue, L., Morris, S. W., Wasik, M. A., & Skórski, T. (2001) · PubMed · Cited by 258
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors
Chiarle, R., Gong, J. Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W. J., Dhall, G., Howes, J., Piva, R., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1343 · Cited by 252
Self-citationAn SCF-like ubiquitin ligase complex that controls presynaptic differentiation
Liao, E. H., Hung, W., Abrams, B., & Zhen, M. (2004) · Nature · doi:10.1038/nature02647 · Cited by 233
Anaplastic lymphoma kinase proteins in growth control and cancer
Pulford, K., Morris, S. W., & Turturro, F. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.10472 · Cited by 227
Expression of the ALK Tyrosine Kinase Gene in Neuroblastoma
Lamant, L., Pulford, K., Bischof, D., Morris, S. W., Mason, D. Y., Delsol, G., & Mariamé, B. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65042-0 · Cited by 226
Rizvi, M. A., Evens, A. M., Tallman, M. S., Nelson, B. P., & Rosen, S. T. (2006) · Blood · doi:10.1182/blood-2005-03-1306 · Cited by 223
Fischer, P., Nacheva, E., Mason, D., Sherrington, P., Hoyle, C., Hayhoe, F., & Karpas, A. (1988) · Blood · doi:10.1182/blood.v72.1.234.234 · Cited by 215
Horie, R., Watanabe, T., Morishita, Y., Ito, K., Ishida, T., Kanegae, Y., Saito, I., Higashihara, M., Mori, S., Kadin, M. E., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205337 · Cited by 207
Lamant, L., Reyniès, A. D., Duplantier, M.-M., Rickman, D. S., Sabourdy, F., Giuriato, S., Brugières, L., Gaulard, P., Espinos, E., & Delsol, G. (2007) · Blood · doi:10.1182/blood-2006-06-028969 · Cited by 203
Vega, F., Medeiros, L. J., Leventaki, V., Atwell, C., Cho-Vega, J. H., Tian, L., Claret, F.-X., & Rassidakis, G. Z. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3018 · Cited by 196
Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers
Lee, H.-H., Norris, A., Weiss, J. B., & Frasch, M. (2003) · Nature · doi:10.1038/nature01916 · Cited by 194
Bilsland, J. G., Wheeldon, A., Mead, A., Znamenskiy, P., Almond, S., Waters, K. A., Thakur, M., Beaumont, V., Bonnert, T. P., Heavens, R., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301446 · Cited by 188
Pleiotrophin Signaling through Anaplastic Lymphoma Kinase Is Rate-limiting for Glioblastoma Growth
Powers, C., Aigner, A., Stoica, G. E., McDonnell, K., & Wellstein, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112354200 · Cited by 183
Jeb signals through the Alk receptor tyrosine kinase to drive visceral muscle fusion
Englund, C., Lorén, C. E., Grabbe, C., Varshney, G. K., Deleuil, F., Hallberg, B., & Palmer, R. H. (2003) · Nature · doi:10.1038/nature01950 · Cited by 179
Han, Y., Amin, H. M., Franko, B., Frantz, C., Shi, X., & Lai, R. (2006) · Blood · doi:10.1182/blood-2006-04-017434 · Cited by 179
Characterization of the expression of the ALK receptor tyrosine kinase in mice
Vernersson, E., Khoo, N. K. S., Henriksson, M. L., Roos, G., Palmer, R. H., & Hallberg, B. (2006) · Gene Expression Patterns · doi:10.1016/j.modgep.2005.11.006 · Cited by 178
Colleoni, G. W. B., Bridge, J. A., Garicochea, B., Liu, J., Filippa, D. A., & Ladanyi, M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64945-0 · Cited by 174
ALK receptor tyrosine kinase promotes cell growth and neurite outgrowth
Motegi, A., Fujimoto, J., Kotani, M., Sakuraba, H., & Yamamoto, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01183 · Cited by 167
Debelenko, L. V., Arthur, D. C., Pack, S. D., Helman, L. J., Schrump, D. S., & Tsokos, M. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000088856.49388.ea · Cited by 163
Piva, R., Pellegrino, E., Mattioli, M., Agnelli, L., Lombardi, L., Boccalatte, F., Costa, G., Ruggeri, B. A., Cheng, M., Chiarle, R., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29401 · Cited by 163
Self-citationBazigou, E., Apitz, H., Johansson, J., Lorén, C. E., Hirst, E. M. A., Chen, P.-L., Palmer, R. H., & Salecker, I. (2007) · Cell · doi:10.1016/j.cell.2007.02.024 · Cited by 161
Moog-Lutz, C., Degoutin, J., Gouzi, J. Y., Frobert, Y., Carvalho, N. B.-D., Bureau, J., Créminon, C., & Vigny, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501972200 · Cited by 158
Kasprzycka, M., Marzec, M., Liu, X., Zhang, Q., & Wasik, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603507103 · Cited by 154
FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
Roncador, G., García, J. F., García, J. F., Maestre, L., Lucas, E., Menárguez, J., Ohshima, K., Nakamura, S., Banham, A. H., & Piris, M. A. (2005) · Leukemia · doi:10.1038/sj.leu.2403965 · Cited by 149
Pérez‐Piñera, P., Zhang, W., Chang, Y., Vega, J. A., & Deuel, T. F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704505200 · Cited by 143
Jazii, F. R. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i44.7104 · Cited by 141
Non‐muscle myosin heavy chain (MYH9): A new partner fused to ALK in anaplastic large cell lymphoma
Lamant, L., Gascoyne, R. D., Duplantier, M.-M., Armstrong, F., Raghab, A., Chhanabhai, M., Rajcan‐Separovic, E., Raghab, J., Delsol, G., & Espinos, E. (2003) · Genes Chromosomes and Cancer · doi:10.1002/gcc.10232 · Cited by 141
Development of anaplastic lymphoma kinase (ALK) small‐molecule inhibitors for cancer therapy
Li, R., & Morris, S. W. (2007) · Medicinal Research Reviews · doi:10.1002/med.20109 · Cited by 138
Amin, H. M., Medeiros, L. J., Ma, Y., Feretzaki, M., Das, P., Leventaki, V., Rassidakis, G. Z., O’Connor, S. L., McDonnell, T. J., & Lai, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206849 · Cited by 137
Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma
Du, X., Hu, H., Lin, D., Xia, S.-H., Shen, X., Zhang, Y., Luo, M., Feng, Y., Cai, Y., Xu, X., et al. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0159-4 · Cited by 136
Souttou, B., Carvalho, N. B.-D., Raulais, D., & Vigny, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007333200 · Cited by 133
Zhang, Q., Wang, H. Y., Liu, X., & Wasik, M. A. (2007) · Nature Medicine · doi:10.1038/nm1659 · Cited by 132
Armstrong, F., Duplantier, M.-M., Trempat, P., Hiéblot, C., Lamant, L., Espinos, E., Racaud‐Sultan, C., Allouche, M., Campo, E., Delsol, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207813 · Cited by 129
Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas
Piva, R., Chiarle, R., Manazza, A. D., Taulli, R., Simmons, W. R., Ambrogio, C., d’Escamard, V., Pellegrino, E., Ponzetto, C., Palestro, G., et al. (2005) · Blood · doi:10.1182/blood-2005-05-2125 · Cited by 128
Self-citationFusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor
Panagopoulos, I., Nilsson, T., Domanski, H. A., Isaksson, M., Lindblom, P., Mertens, F., & Mandahl, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.21490 · Cited by 126
Expression and functional analysis of the anaplastic lymphoma kinase (ALK) gene in tumor cell lines
Dirks, W. G., Fähnrich, S., Lis, Y., Becker, E., MacLeod, R. A. F., & Drexler, H. G. (2002) · International Journal of Cancer · doi:10.1002/ijc.10435 · Cited by 125
Pleiotrophin is a neurotrophic factor for spinal motor neurons
Mi, R., Chen, W., & Höke, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603243104 · Cited by 125
Thompson, M. A., Stumph, J. R., Henrickson, S. E., Rosenwald, A., Wang, Q., Olson, S. J., Brandt, S. J., Roberts, J., Zhang, X., Shyr, Y., et al. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.03.004 · Cited by 118
Gu, T., Tóthová, Z., Scheijen, B., Griffin, J. D., Gilliland, D. G., & Sternberg, D. (2004) · Blood · doi:10.1182/blood-2003-03-0820 · Cited by 117
Miyake, I., Hakomori, Y., Shinohara, A., Gamou, T., Saito, M., Iwamatsu, A., & Sakai, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205735 · Cited by 116
Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
Pulford, K., Falini, B., Banham, A. H., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1605 · Cited by 115
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
Crockett, D. K., Lin, Z., Elenitoba‐Johnson, K. S. J., & Lim, M. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207398 · Cited by 113
Marzec, M., Kasprzycka, M., Liu, X., El-Salem, M., Halasa, K., Raghunath, P. N., Bucki, R., Wlodarski, P. K., & Wasik, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210346 · Cited by 113
Mourali, J., Bénard, A., Lourenço, F. C., Monnet, C., Greenland, C., Moog‐Lutz, C., Racaud‐Sultan, C., Gonzalez‐Dunia, D., Vigny, M., Mehlen, P., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01515-05 · Cited by 113
Monoclonal Antibodies in the Treatment of Non-Hodgkin???s Lymphoma
Fanale, M. A., & Younes, A. (2007) · Drugs · doi:10.2165/00003495-200767030-00002 · Cited by 111
Diversity of Genomic Breakpoints in TFG-ALK Translocations in Anaplastic Large Cell Lymphomas
Hernández, L., Beà, S., Bellosillo, B., Pinyol, M., Falini, B., Carbone, A., Ott, G., Rosenwald, A., Fernández, A., Pulford, K. A. F., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62574-6 · Cited by 107
Nieborowska-Skorska, M., Słupianek, A., Xue, L., Zhang, Q., Raghunath, P. N., Hoser, G., Wasik, M. A., Morris, S. W., & Skórski, T. (2001) · PubMed · Cited by 106
Wan, W., Albom, M. S., Lü, L., et al. (2005) · Blood · doi:10.1182/blood-2005-08-3254 · Cited by 106
Voena, C., Conte, C., Ambrogio, C., Erba, E. B., Boccalatte, F. E., Mohammed, S., Jensen, O. N., Palestro, G., Inghirami, G., & Chiarle, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4350 · Cited by 103
Self-citationThe NPM-ALK and the ATIC-ALK Fusion Genes Can Be Detected in Non-Neoplastic Cells
Maes, B., Vanhentenrijk, V., Włodarska, I., Cools, J., Peeters, B., Marynen, P., & Wolf‐Peeters, C. D. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64690-1 · Cited by 101
Trümper, Pfreundschuh, Bonin, & Daus (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01097.x · Cited by 88
Leventaki, V., Drakos, E., Medeiros, L. J., Lim, M. S., Elenitoba‐Johnson, K. S. J., Claret, F. X., & Rassidakis, G. Z. (2007) · Blood · doi:10.1182/blood-2006-11-059451 · Cited by 86
NIPA Defines an SCF-Type Mammalian E3 Ligase that Regulates Mitotic Entry
Bassermann, F. C., von Klitzing, C., Münch, S., Bai, R.-Y., Kawaguchi, H., Morris, S. W., Peschel, C., & Duyster, J. (2005) · Cell · doi:10.1016/j.cell.2005.04.034 · Cited by 84
Wright, C. W., Rumble, J. M., & Duckett, C. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608817200 · Cited by 84
p130Cas mediates the transforming properties of the anaplastic lymphoma kinase
Ambrogio, C., Voena, C., Manazza, A. D., Piva, R., Riera, L., Barberis, L., Costa, C., Tarone, G., Defilippi, P., Hirsch, E., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1204 · Cited by 84
Self-citationOverexpression of NPM–ALK induces different types of malignant lymphomas in IL-9 transgenic mice
de Lange, K., Uckert, W., Blankenstein, T. J. F., Nadrowitz, R., Bittner, C., Renauld, J., Snick, J. V., Feller, A. C., & Merz, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206076 · Cited by 74
Han, Y. T., Amin, H. M., Frantz, C. E., Franko, B., Lee, J., Lin, Q., & Lai, R. L. (2006) · Leukemia · doi:10.1038/sj.leu.2404323 · Cited by 74
Horie, R., Watanabe, M., Ishida, T., Koiwa, T., Aizawa, S., Itoh, K., Higashihara, M., Kadin, M. E., & Watanabe, T. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00084-4 · Cited by 73
Marzec, M., Kasprzycka, M., Ptasznik, A., Wlodarski, P. K., Zhang, Q., Ødum, N., & Wasik, M. A. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700348 · Cited by 73
Colomba, A., Courilleau, D., Ramel, D., Billadeau, D. D., Espinos, E., Delsol, G., Payrastre, B., & Gaits‐Iacovoni, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210921 · Cited by 71
Wellmann, A., Doseeva, V., Butscher, W. G., Raffeld, M. A., Fukushima, P. I., Stetler‐Stevenson, M., & Gardner, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.12.9337149 · Cited by 69
Turner, S. D., Tooze, R. M., MacLennan, K., & Alexander, D. R. (2003) · Oncogene · doi:10.1038/sj.onc.1207048 · Cited by 69
Mathivet, T., Mazot, P., & Vigny, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.07.011 · Cited by 65
Bacchiocchi, R., Baldanzi, G., Carbonari, D., Capomagi, C., Colombo, E., van Blitterswijk, W. J., Graziani, A., & Fazioli, F. (2005) · Blood · doi:10.1182/blood-2005-01-0316 · Cited by 65
Kadin, M. E., & Morris, S. W. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809068562 · Cited by 65
SHP1 tyrosine phosphatase negatively regulates NPM-ALK tyrosine kinase signaling
Honorat, J.-F., Ragab, A., Lamant, L., Delsol, G., & Ragab-Thomas, J. M. F. (2006) · Blood · doi:10.1182/blood-2005-06-2421 · Cited by 59
Liu, Q., & Chan, P. K. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16236.x · Cited by 59
Ouyang, T., Bai, R.-Y., Bassermann, F. C., von Klitzing, C., Klümpen, S., Miething, C., Morris, S. W., Peschel, C., & Duyster, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300883200 · Cited by 57
Armstrong, F., Lamant, L., Hiéblot, C., Delsol, G., & Touriol, C. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.12.005 · Cited by 55
Nucleophosmin/B23 (NPM) oligomer is a major and stable entity in HeLa cells
Chan, P. K., & Chan, F. Y. (1995) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(95)00044-h · Cited by 54
Siebert, R., Gesk, S., Harder, L., et al. (1999) · PubMed · doi:10.1182/blood.v94.10.3614.422a38e_3614_3617 · Cited by 49
Raetz, E. A., Perkins, S. L., Carlson, M. A., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64248-4 · Cited by 45
Passoni, L., Gallo, B. M., Biganzoli, E. M., Stefanoni, R., Massimino, M., Nicola, M. D., Gianni, A. M., & Gambacorti-Passerini, C. B. (2006) · PubMed · Cited by 45
Yang, H., Eriksson, T., Vernersson, E., et al. (2007) · Journal of Experimental Zoology Part B Molecular and Developmental Evolution · doi:10.1002/jez.b.21146 · Cited by 41
Bäsecke, J., Cepek, L., Mannhalter, C., Krauter, J., Hildenhagen, S., Brittinger, G., Trümper, L. H. P., & Griesinger, F. (2002) · Blood · doi:10.1182/blood-2002-06-1673 · Cited by 41
Elenitoba‐Johnson, K. S. J., Crockett, D. K., Schumacher, J. A., Jenson, S. D., Coffin, C. M., Rockwood, A. L., & Lim, M. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506514103 · Cited by 40
Bassermann, F. C., von Klitzing, C., Illert, A. L., Münch, S., Morris, S. W., Pagano, M., Peschel, C., & Duyster, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610819200 · Cited by 31
Cited by
Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
Shaw, A. T., Yeap, B. Y., Mino-Kenudson, M., Digumarthy, S. R., Costa, D. B., Heist, R. S., Solomon, B., Stubbs, H., Admane, S., McDermott, U., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6993 · Cited by 1,870
Identification of ALK as a major familial neuroblastoma predisposition gene
Mossé, Y. P., Laudenslager, M., Longo, L., Cole, K. A., Wood, A., Attiyeh, E. F., Laquaglia, M. J., Sennett, R., Lynch, J. E., Perri, P., et al. (2008) · Nature · doi:10.1038/nature07261 · Cited by 1,407
Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers
Katayama, R., Shaw, A. T., Khan, T. M., Mino-Kenudson, M., Solomon, B. J., Halmos, B., Jessop, N. A., Wain, J. C., Yeo, A. T., Benes, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003316 · Cited by 1,309
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Janoueix-Lerosey, I., Lequin, D., Brugières, L., Ribeiro, A., de Pontual, L., Combaret, V., Raynal, V., Puisieux, A., Schleiermacher, G., Pierron, G., et al. (2008) · Nature · doi:10.1038/nature07398 · Cited by 894
Metadata
- Authors
- Chiarle, R., Voena, C., Ambrogio, C., Piva, R., & Inghirami, G.
- Venue
- Nature Reviews Cancer
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 11-23
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2061278019
- Cited by
- 882
- References
- 121
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.